| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.006 | 0.9 |